Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=alksLatest Financial News for Alkermes, Inc.en-usWed, 23 Dec 2009 19:43:52 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=134vqg8b5/*http%3A//www.fool.com/investing/small-cap/2009/12/23/buy-this-stock-before-your-neighbor-does.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3147424062Wed, 23 Dec 2009 19:43:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091218/180567.html?.v=1yahoo_finance/1753075994Fri, 18 Dec 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/28397.html?.v=1Exenatide once weekly is currently being reviewed by the U.S. Food and Drug Administration ; a response should be out in the first quarter of 2010.yahoo_finance/3914593934Wed, 16 Dec 2009 21:54:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh86309_2009-12-15_15-25-50_sge5be0j8_newsml&rpc=44&type=marketsNewsyahoo_finance/1274788825Tue, 15 Dec 2009 15:25:50 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11h7vkhqe/*http%3A//www.cnbc.com/id/34428867/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/3190692456Tue, 15 Dec 2009 14:24:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/la25979.html?.v=1Amylin Pharmaceuticals, Inc. , Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® injection taken twice daily, in patients with type 2 diabetes.yahoo_finance/2914875578Tue, 15 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=132qdmunl/*http%3A//www.fool.com/investing/general/2009/12/14/finally-released-from-an-extended-review.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3074086678Mon, 14 Dec 2009 19:21:11 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091208/20091208006487.html?.v=1CAMBRIDGE, Mass.----Alkermes, Inc. announced today that its corporate presentation will be webcast live by Deutsche Bank on Tuesday, December 15, 2009, at 11:30 a.m. ET from the Four Seasons Hotel in Boston.yahoo_finance/1583572552Tue, 8 Dec 2009 21:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12824i0e6/*http%3A//boston.bizjournals.com/boston/stories/2009/11/30/daily56.html?ana=yfcpcyahoo_finance/2140855574Thu, 3 Dec 2009 20:05:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091203/alks8-k.htmlyahoo_finance/1004727268Thu, 3 Dec 2009 17:08:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091203/20091203005922.html?.v=1CAMBRIDGE, Mass.----Alkermes, Inc. and Acceleron Pharma, Inc. today announced that Alkermes has licensed a proprietary long-acting Fc fusion technology platform, called the Medifusion™ technology, which is designed to extend the circulating half-life of proteins and peptides.yahoo_finance/1194539541Thu, 3 Dec 2009 17:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12s0gqqc5/*http%3A//www.fool.com/investing/general/2009/11/24/4-platform-drugmakers-to-invest-in.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/445904775Tue, 24 Nov 2009 20:20:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmpe/rss/SIG=12c7i0ta5/*http%3A//www.thestreet.com/p/_yahoo/rmoney/technicalanalysis/10629453.html?cm_ven=YAHOO&cm_cat=PREMIUM&cm_ite=003190yahoo_finance/34078502Fri, 20 Nov 2009 14:37:28 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ts/091119/10628883.html?.v=1Can positive trial data drive the stock higher despite new competition for a key product?yahoo_finance/1716816030Thu, 19 Nov 2009 14:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091118/27409.html?.v=1yahoo_finance/4183284204Wed, 18 Nov 2009 14:51:26 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12gc2bjqh/*http%3A//seekingalpha.com/article/173994-tuesday-s-big-gainers-on-heavy-volume?source=yahooyahoo_finance/1145071871Wed, 18 Nov 2009 11:00:48 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ifvrdra/*http%3A//online.wsj.com/article/SB10001424052748704538404574542072072166770.html?ru=yahoo&mod=yahoo_hsyahoo_finance/2602882257Wed, 18 Nov 2009 02:33:20 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12qok0iod/*http%3A//www.marketwatch.com/news/story/alkermes-gains-cerus-intermune-tumble/story.aspx?guid=%7BCE805CDE%2D5B4A%2D4EC5%2DA25C%2D2D168B41364F%7D&siteid=yhoofDrug stocks dip in afternoon action, while shares of Alkermes gain on positive news about two of its substance-abuse therapies.yahoo_finance/3290217361Tue, 17 Nov 2009 19:04:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12uqtni5e/*http%3A//www.fool.com/investing/general/2009/11/17/4-star-stocks-poised-to-pop-alkermes.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3590914343Tue, 17 Nov 2009 14:28:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091117/20091117005294.html?.v=1CAMBRIDGE, Mass.----Alkermes, Inc. today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders.yahoo_finance/3189540081Tue, 17 Nov 2009 13:30:00 Etc/GMT